Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Omega-3 essential fatty acids

This article was originally published in The Tan Sheet

Executive Summary

And their relation to psychiatric disorders is the topic of an NIH workshop to be held Sept. 2-3 to "facilitate discussion among international investigators who are examining clinical applications of essential fatty acids in psychiatric disorders and to introduce this rapidly emerging field to clinical psychiatric research." The meeting is sponsored by the NIH Office of Dietary Supplements, the Office of Research on Women's Health, the National Institute on Alcohol Abuse & Alcoholism and the National Institute on Mental Health. The meeting is to be held at the NIH Campus in Bethesda, Md., Natcher Building auditorium beginning at 8 a.m. both days. Registration is free; contact Linda Crafts at (301) 496-4452 for more information or visit www.nimh.nih.gov/events/omega.htm...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088763

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel